Reduced yields of poliovirus and foot-and-mouth disease virus are obtained in suspended cell cultures in the presence of rifampicin. The effect of the drug appears to be related to virus replication and not to a toxic effect on the host cells. The inhibition is reversed upon removal of the drug. The replication of both picornaviruses in suspended cultures is affected by actinomycin D, but not by mitomycin C. Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11 On: Sun, 30 Dec 2018 11:22:47 Replication of poliovirus and FMD V 299 8
INTRODUCTION
Poliovirus and foot-and-mouth disease virus are small viruses containing RNA, which multiply in the cytoplasm, apparently without participation of the host cell genome. However, poliovirus growth is affected by actinomycin D in some cell systems (Grado, Fisher & Contreras, ~965; Cooper, I966; Schaffer & Gordon, I966) . The effect of actinomycin D on foot-and-mouth disease virus growth is questionable (Polatnick & Arlinghaus, 2967; Black & Brown, 1968) . Although it could be expected that mitomycin C would not affect picornavirus replication, it has been reported to inhibit foot-and-mouth disease virus production in BHK cell monolayers (Black & Brown, ~968) .
Low concentrations of the antibiotic rifampicin inhibit bacterial RNA synthesis by interacting with DNA-dependent RNA polymerase (Wehrli et al. 2968) , while mammalian RNA polymerase is affected at higher concentrations (Umezawa et al. I968) . Besides bacteria, this antibiotic has been reported to inhibit the growth of RNA bacteriophages (Fromageot & Zinder, I968; Marino, I968) . Passent & Kaesberg (I971) , working with Qfl phage have shown that phage assembly, a late event of virus cycle, is inhibited in the presence of rifampicin. Several investigators have shown that rifampicin inhibits growth ofpoxviruses (Heller et al. 2969 ; Subak-Sharpe, Timbury & Williams, I969). Moreover, this effect seems to be related to early maturational events which precede the formation of the virus core (Katz & Moss, z97o) .
In this report, evidence is presented that, using cell suspensions, the replication of both picornaviruses is inhibited by rifampicin and actinomycin D, while it is little affected by mitomycin C.
METHODS

Viruses.
Poliovirus type I, Brunhilda strain, grown in HEp-2 cell monolayers, was partially purified by column chromatography (Levintow & Darnell, 196o) . Foot-and-mouth disease virus, type O1, was propagated for at least five passages in primary baby pig kidney and/or in IB-RS-2, clone I3, cell monolayers (de Castro, I964), according to the host cells used on virus growth experiments. In order to study single-step virus growth, suspended cell cultures were made as follows. Primary baby pig kidney and IB-RS-2 cell monolayers were detached by means of trypsin (de Castro, 1964) . EDTA containing 2 % bovine serum was used in the case of HEp-2 cells (Grado et al. 1965) . The cells were suspended at a final concentration of I x lO 6 cells/ml in complete growth media containing 5 % heat-inactivated bovine serum. After 3o min adaptation to the rotatary drum (45 rev/min), the cells were infected with poliovirus at an input multiplicity of 15 p.f.u./cell, or with foot-and-mouth disease virus at an input multiplicity of 2 p.f.u./cell. For some experiments, rifampicin was removed by centrifuging the cell suspension at IOOO rev/min for 5 min. The cell pellet was washed with growth media and resuspended at a similar cell concentration in the designed experimental media. Samples for virus assay were taken between o and 8 h post-infection. Viable and dead cells were counted after staining with trypan blue. Virus was harvested by freezing and thawing; the plaque assay was made in triplicate on the corresponding cell monolayers under agar.
Rifampicin was kindly donated by Ciba Laboratories. Actinomycin D was the gift of the Merck, Sharp and Dohme Research Laboratory.
Mitomycin C was obtained from Kyowa Hakko Kgyo Co., Japan. The drugs were dissolved in 5o % ethanol (v/v) at a concentration of I mg/ml shortly before use. A similar amount of 5o % ethanol was added to the controls.
RESULTS
Primary baby pig kidney cell cultures can be kept in suspension for about IO h without loss of cell viability. HEp-2 cell monolayers can be suspended for as long as 24 to 48 h. Rifampicin is harmless to suspended IB-RS-2 cells; doses of 5 to 2o/zg/i@ cells did not increase cell death during the experimental period. The viability of HEp-2 cells treated with 20 #g of rifampicin/ml is not altered when left in suspension for 24 h. In order to assess the possible toxicity of rifampicin, suspended HEp-z cells treated with the drug were plated out on glass (Table I) . In this experiment a confluent monolayer of HEp-2 cells, detached as usual with EDTA, was suspended at a concentration of about lO 6 cells/ml. After 3o min adaptation to the rotatory drum, 50/zg of rifampicin/ml was added to half of the cells; the remainder were kept as control. The cell count at o, I, 3 and 6 h is similar for both groups. At 6 h, the cell suspensions were diluted I : I in the same media and plated out on glass. It can be seen that rifampicin does not alter the plating efficiency of HEp-2 cells. Even after 48 h, neither the microscopical appearance, nor the cell viability shows any difference with respect to the control cells. Mitomycin C does not alter the viability of HEp-z cells nor primary cell suspensions. Actinomycin D is not toxic for the primary cultures even at a dose of 5/~g/Io6 cells. When the cell suspensions were treated with different doses of rifampicin, 30 min prior to virus infection, it was found that the replication of foot-and-mouth disease virus and poliovirus were similarly affected ( Fig. i ). In the same Fig. we have plotted the effect of actinomycin D and mitomycin C on the growth of these viruses. Virus production, expressed as percentage of the controls, refers to one cycle of virus replication, i.e. 4 h for foot-andmouth disease virus and 6 h for poliovirus. Each point represents the mean value of 5 to Io expts. It can be seen that in the presence of rifampicin, reduced virus yields are obtained, which depend on the drug concentration. With 2o #g of rifampicin/Io 6 cells, the replication of both picornaviruses is inhibited 9 ° to 95 ~. When the input multiplicity of poliovirus is increased to 15 ° p.f.u./cell, that is I o-fold, the same degree of inhibition is obtained. Actinomycin D, at a dose of 5 #g/Io6 cells, inhibits foot-and-mouth disease virus growth by 97 ~, in primary baby pig kidney cell suspensions, while a concentration of 6/zg/Io ~ cells reduces poliovirus yield by 8o ~ in HEp-2 cells. Mitomycin C, up to a dose of 4o/zg/i@ cells, has only a slight inhibitory effect on foot-and-mouth disease virus and on poliovirus replication. Fig. 2a shows the growth curve of foot-and-mouth disease virus in IB-RS-2 cells; the pattern of virus development is not altered by actinomycin D, although the final yield is reduced. The same is true for poliovirus grown in HEp-2 cells treated with rifampicin A, 4o #g rifampicin/io 6 cells.
( Fig. 2 b) . The initial eclipse is the same, but final virus production is inhibited; the phenomenon does not seem to be due to slow down of virus development, since samples taken later did not reveal any further differences. Table 2 shows the effect of rifampicin on poliovirus yield when added before, at, or after infection. Virus inhibition is of the same order of magnitude, regardless on the time of addition of the drug. Similar results were obtained with foot-and-mouth disease virus grown in IB-RS-2 cells.
In order to test whether the effect of rifampicin is reversible, we have studied poliovirus yield in HEp-2 cells when the drug is removed either at the time of infection, of late during the process of virus replication. Table 3 shows that HEp-2 cells treated for o'5 h with 4 ° #g of rifampicin/ml, followed by its removal immediately prior to infection, support virus growth as efficiently as non-treated control cells. By contrast, the same dose of rifampicin inhibits poliovirus growth by 9 ° ~. Table 4 shows that the inhibitory effect of rifampicin is reversible, since the removal of the drug 3 h post-infection results in potiovirus production. Upon removal of rifampicin, the yield of poliovirus in suspended HEp-z cells is somehow less than in the absence of the drug. However, the increase of virus production between 6 and 8 h is the same for both groups. 3'5 x io 8 6.0 x io a I'OX IO 8 2"OX IO 8 5"OX IO 7 5'OX IO 7
DISCUSSION
The experimental data presented show that the growth of foot-and-mouth disease virus in primary suspended cell cultures is inhibited by actinomycin D. Black & Brown 0968) obtained 20 to 4o ~ virus yield in BHK cell monolayers, provided that the drug is added within I h after infection; these observations coincide with our findings in suspended cells. Previously, it has been demonstrated that the timing of actinomycin D addition is crucial for the inhibition of poliovirus production in several host cells (Grado et aL I965; Schaffer & Gordon, I966). Even though Polatnick & Arlinghaus (1967) could not detect reduced infective titres of foot-and-mouth disease virus in BHK celt monolayers, they showed that virus RNA polymerase is inhibited, by about 5 ° ~o, in the presence of the drug. All the experiments we have described have been carried out with complete growth media enriched with bovine serum. We have tested different batches of serum; with all of them the same degree of inhibition has been obtained for both picornaviruses. The nature of the early inhibitory effect of actinomycin D is still unsolved; this antibiotic has no effect on either virus adsorption or its uncoating (Cooper, I966 ) . However, it is unlikely that host cell DNA binding by actinomycin D is responsible for this inhibition, since mitomycin C has almost no effect on the growth of both picornaviruses. The cells are permeable to mitomycin C; a dose of 4 °/~g/io 6 cells reduces the incorporation of [3H]-thymidine into DNA of suspended HEp-2 cells by 4o ~ and 15 ~ at 3 and 6 h, respectively.
It was surprising to find that reduced virus yields are obtained in the presence of rifampicin in suspended cultures. Other investigators (Heller et al. 1969; Subak-Sharpe et al. I969) have reported that this drug does not alter virus production of several RNA viruses, including picornavirus, when tested in cell monolayers. We have studied the influence of Io to IOO/~g of rifampicin/ml on the c.p.e, of poliovirus in HEp-2 cell monolayers, and similar doses on the IDs0 of foot-and-mouth disease virus in primary baby pig kidney cell monolayers. Under these conditions, rifampicin did not reduce the IDs0 titre of either of the viruses. Thus, we have found that the inhibitory effect of rifampicin on the growth of these picornaviruses is detectable only in suspended cell cultures. These cultures have been used routinely in our laboratory since they allow us to follow a single-cycle of virus development. HEp-2 cells can be kept in suspension for as long as 48 h without loss of cell viability. During the first 8 h of suspension, we have observed that the rate of DNA, RNA and protein synthesis is constant, as measured by radioisotope pulses (laboratory observations). On the other hand, rifampicin appears to be harmless to the host cells in study. First, higher doses than those required to inhibit virus growth, did not alter the viability of either HEp-2 cells nor IB-RS-2 cells after suspending their monolayers for 24 h. Secondly, after 6 h treatment with 50 #g of rifampicin/ml, suspended HEp-2 cells clone as efficiently as the controls. In addition, pre-treatment of these cultures before poliovirus infection with the same dose of rifampicin did not alter their capability to support poliovirus growth. Considering that the inhibitory effect of rifampicin cannot be ascribed to a toxic effect on the host ceils, it is reasonable to assume that the difference observed between monolayers and suspended cells might reflect alterations in cell membrane after the treatment with either trypsin or versene which is required to detach the monolayers.
Rifampicin does not lead to virus particle inactivation. Both adsorption and eclipse appear to be normal, as deduced from the virus growth curve pattern. Besides, rifampicin is equally inhibitory when added 30 min post-infection, that is, when virus adsorption is over. As in the poxvirus system, the effect of rifampicin is reversible, since removal of the drug late during virus replication results in a rapid production of poliovirus in suspended HEp-2 cells. The latter observation suggests that the action of rifampicin on both poliovirus and foot-and-mouth disease virus replication is most likely to reside on the process of maturation, probably at an earlier stage of the precursor polypeptide cleavage (Summers & Maizel, ~968) , as shown for vaccinia virus (Katz & Moss, I97o) . This work has been partially supported by a grant from CONICYT. We thank Miss Carmen Cortes, Miss Yolanda Miranda and Mr Adan Acosta for their technical assistance.
